Advancing scientific understanding of immune-mediated dermatological diseases.

Janus kinase 1 inhibitor

Knowledge Center

With a deep commitment to scientific rigor, we are advancing the understanding of immune-mediated dermatological diseases and conditions.

Interested in collaborating with us?

Have an idea for an Investigator-Initiated Trial (IIT)?

Seeking support for independent Medical Education?

Connect with Medical Information or a Medical Science Liaison.

This website is intended for US healthcare professionals only. There may be information included that pertains to an investigational therapy or formulation that has not yet been approved for use in your country. The safety and efficacy of investigational therapies and/or formulations and/or uses have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated. This information is as of 12/2023 to the best of the Company’s knowledge and Arcutis assumes no obligation to update this information.

© 2024 Arcutis Biotherapeutics, Inc. All rights reserved. MED-MULTI-2100006 v5.0 12/23